Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Morgan Stanley Maintains Equal-Weight on Illumina, Raises Price Target to $105

Author: Benzinga Newsdesk | August 04, 2025 10:42am
Morgan Stanley analyst Tejas Savant maintains Illumina (NASDAQ:ILMN) with a Equal-Weight and raises the price target from $100 to $105.

Posted In: ILMN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist